期刊論文1. | Shu, Jian-Jun(2017)。A new integrated symmetrical table for genetic codes。Biosystems,151,21-26。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
2. | Jansen, T. L. C.、Knoester, J.(2008)。Two-Dimensional Infrared Population Transfer Spectroscopy for Enhancing Structural Markers of Proteins。Biophysical Journal,94(5),1818-1825。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
3. | 林治華、李元鳳、王蓉君(2011)。生物相似性藥品Biosimilar。當代醫藥法規,3。 延伸查詢![new window](/gs32/images/newin.png) |
4. | Wegner, Harold C.(2004)。The Disclosure Requirements of the 1952 Patent Act: Looking Back and a New Statute for the Next Fifty Years。Akron law review,37,243-262。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
5. | 陳秉訓(20081200)。美國聯邦巡迴上訴法院2001年In re Wako Pure Chemical Industries Ltd.案之分析--以專利請求項和優先權主張間之關係為中心。智慧財產權月刊,120,119-133。 延伸查詢![new window](/gs32/images/newin.png) |
6. | Holman, Christopher M.(2011)。Unpredictability in Patent Law and Its Effect on Pharmaceutical Innovation。Missouri law review,76(3),645-694。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
7. | Vetter, Greg R.(2011)。Patent Law's Unpredictability Doctrine and the Software Arts。Missouri Law Review,76(3),763-812。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
8. | Naini, Amir A.(2004)。Convergent technologies and divergent patent validity doctrines: obviousness and disclosure analyses in software and biotechnology。Journal of the Patent and Trademark Office Society,86(7),541-567。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
9. | Passino, Sean A.、Rocklin, Amy M.、Maebius, Stephen B.(2004)。Written Description Traps for Antibody Claims。Journal of the Patent and Trademark Office Society,86(4),317-319。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
10. | Kurosawa, K.、Lin, W.、Ohta, K.(2014)。Chimeric antibodies。Methods in Molecular Biology,1060,139-148。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
11. | Ledford, Heidi(2018)。Rush to protect lucrative antibody patents kicks into gear。Nature,557(7707),623-624。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
12. | De Luca, Carmela、Trifonova, Anastassia(2017)。Patent disclosure requirements for therapeutic antibody patents。Expert Opinion on Therapeutic Patents,27(8),867-875。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |